IEIH iShares Evolved US Innvtv Hlthcare ETF
S&P Total Market TR USD

NAV as of 13-May-2022

31.8701

4 Week: 30.75 - 34.51

52 Week: 30.75 - 37.61

Latest Closing Price

31.87

Premium / Discount

0.09

Expense Ratio

0.18%

Investment Objective

The investment seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system. The fund invests, under normal circumstances, at least 80% of its net assets in U.S. listed common stock of large-, mid- and small-capitalization pharmaceutical and biotechnology companies. It will hold common stock of those companies that fall into the Innovative Healthcare Evolved Sector which have economic characteristics that have been historically correlated with companies traditionally defined as pharmaceutical and biotechnology companies. The fund is non-diversified.

Main Fund Characteristics

Fund Manager:
iShares
Asset Under Management:
34,558,034
Launch Date:
20/03/2018
Asset Class:
Equity
Replication Method:
Not Applicable
Number of Holdings:
273
Trading Currency:
USD
Style:
Large Blend
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
CBOEBZX

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-10.121.27-7.94
1 Day1.820.000.00
1 Week0.355.160.07
1 Month-9.487.60-1.25
3 Months-2.8810.71-0.27
6 Months-8.8913.01-0.68
1 Year-2.3216.26-0.14
2 Years9.2224.940.37
3 Years31.6935.480.89
5 Years0.000.000.00
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.00000.00000.00000.000022.109519.141012.3477
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.000067.000058.000040.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
23/03/202229/03/20220.1488
12/12/202116/12/20210.0982
23/09/202129/09/20210.1246
09/06/202115/06/20210.0865
24/03/202130/03/20210.1064
13/12/202017/12/20200.0993
24/03/202030/03/20200.1039
15/12/201919/12/20190.0993
19/03/201925/03/20190.1010
25/09/201801/10/20180.0855

Portfolio Data

Total Number of Holdings: 273

Number of Bond Holdings: 0

Number of Equity Holdings: 271

Total Market Value: 34,558,034

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Johnson & Johnson8.546015,24902,109,852
2Merck & Co Inc6.023919,52201,487,186

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant38.51
Large31.55
Medium15.61
Small8.35
Micro4.43

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

12.3599

Price/Book*

3.9256

Price/Sales*

2.3677

Price/Cash Flow*

10.6492

Dividend Yield*

1.7471

Growth Measures

Long-Term Earnings

8.5763

Historical Earnings

26.9232

Sales Growth

12.9767

Cash-Flow Growth

22.7418

Book-Value Growth

10.3841

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.